In this sectionMore on this Topic

Innovations in Drug Development - September 9, 2015

Share:
Linked InPrintEmail

A. James Clark Distinguished Professorship in Molecular Genetics
Innovations in Drug Development: How Children’s National is Taking a Leadership Role in Faster, Better, and Cheaper Drugs 

Presented by: 

Eric Hoffman, PhD
Director, Research Center for Genetic Medicine, Children’s National
Professor and Chairman, Department of Integrative Systems Biology, George Washington University
Co-Founder, ReveraGen Biopharma

GiveAct

Invest in future cures for some of life's most devastating diseases

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.Make it happen

You Might Also Be Interested In:

Muscular Dystrophies

Muscular dystrophy describes a genetic disorder of the muscles that causes the muscles in the body to become very weak. 

Brain Tumor Institute (Neuro-Oncology Program)

Our Brain Tumor Institute uses a unique approach, tapping in to the expertise of both neurologists and neuro-oncologists, to deliver the best possible care.

Genetics Expert Talks about Tensions Between Parents and Regulators over Duchenne Treatments

In a feature story in Bloomberg Businessweek about Duchenne muscular dystrophy, Eric Hoffman, PhD, discusses the current tension that exists between families and drug regulators.

Rare Diseases Expert Talks about Research in Duchenne Treatments

Eric Hoffman, PhD, discusses the progress in discovering novel treatments for Duchenne muscular dystrophy with the Washington Post.